BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 2, 2010
View Archived Issues
AstraZeneca discloses novel FGFR inhibitors
Read More
Enhanced-sensitivity Trofile assay and HIV V3-loop sequencing comparably predict maraviroc response
Read More
FDA approves new labeling of Xylocaine including updated safety information
Read More
Prosidion claims new glucose-dependent insulinotropic receptor agonists
Read More
Efficacy and safety results of ecallantide treatment for hereditary angioedema attacks
Read More
Phase III study supports once-daily dosing of darunavir/ritonavir in HIV-1 infection
Read More
Genentech identifies novel MEK inhibitors
Read More
Hyperactivity models differentiate SSR-103800 from other antipsychotics
Read More
Orchid Research Laboratories presents new PDE4 inhibitor OCI-2987
Read More
New voltage-gated sodium channel inhibitors described by Vertex
Read More
UCB presents novel PI3K inhibitors
Read More
Novartis and Ono submit manufacturing and marketing application in Japan for rivastigmine
Read More
COMP grants perifosine positive opinion as orphan medicinal product in MM
Read More
Welichem Biotech begins enrollment in phase IIa WBI-1001 trial in psoriasis
Read More
FDA accepts for filing VIVUS' Qnexa NDA for obesity
Read More
Shionogi provides update on its developments in Q3 of 2009
Read More
Ariad's AP-24534 receives orphan drug status for CML
Read More
Watson Pharmaceuticals licenses Population Council's novel contraceptive ring
Read More
Quark Pharmaceuticals begins dosing in phase I trial of QPI-1007 for NAION
Read More
Janssen submits NDA for R-113675 in Japan for AD
Read More
Merck KGaA to acquire Millipore
Read More
GTC Biotherapeutics provides update on TG-20 MAb
Read More
FDA requests Vion conduct phase II trial of Onrigin in AML prior to phase III study
Read More
Acorda Therapeutics' Ampyra launched in U.S. and Puerto Rico
Read More
Icagen reports phase Ib results on ICA-105665 in pain
Read More